External Beam Radiation Therapy - Target Volume
Prostatic Neoplasms
About this trial
This is an interventional treatment trial for Prostatic Neoplasms
Eligibility Criteria
Inclusion Criteria: Patients following radical prostatectomy for prostate adenocarcinoma with one or more of the following adverse features: pT2 + positive surgical margins ) pT3 ) PSA ≤ 2ng/ml Persistently elevated PSA at 3 months ) Patients with initially undetectable PSA following prostatectomy for prostate adenocarcinoma with subsequent PSA relapse Patients being planned for radiation therapy No evidence of distant metastases Age ≥ 18 years ECOG performance status 0 or 1 Informed consent Exclusion Criteria: Contraindications to MRI Patients weighing >136 kgs (weight limit for the scanner tables) Patients with pacemakers, cerebral aneurysm clips, shrapnel injury or implantable electronic devices not compatible with MRI. Severe claustrophobia Inflammatory bowel disease or collagen vascular disease Previous colorectal surgery Previous pelvic radiotherapy
Sites / Locations
- Princess Margaret Hospital
Arms of the Study
Arm 1
Experimental
External Beam Radiation Therapy